PSMC2 Regulates Cell Cycle Progression Through the p21/Cyclin D1 Pathway and Predicts a Poor Prognosis in Human Hepatocellular Carcinoma
Proteasome 26S subunit ATPase 2 (PSMC2) plays a pathogenic role in various cancers. However, its function and molecular mechanism in hepatocellular carcinoma (HCC) remain unknown. In this study, tissue microarray (TMA) analysis showed that PSMC2 is highly expressed in HCC tumors and correlates with...
Main Authors: | Yiwei Liu, Hairong Chen, Xiangcheng Li, Feng Zhang, Lianbao Kong, Xuehao Wang, Jin Bai, Xiaofeng Wu |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-02-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2021.607021/full |
Similar Items
-
PSMC2 is overexpressed in glioma and promotes proliferation and anti-apoptosis of glioma cells
by: Xiaoyang Zheng, et al.
Published: (2022-03-01) -
Silencing of PSMC2 inhibits development and metastasis of prostate cancer through regulating proliferation, apoptosis and migration
by: Qingke Chen, et al.
Published: (2021-04-01) -
PSMC3 promotes RNAi by maintaining AGO2 stability through USP14
by: Yan Jia, et al.
Published: (2022-12-01) -
Pan-cancer analysis identifies proteasome 26S subunit, ATPase (PSMC) family genes, and related signatures associated with prognosis, immune profile, and therapeutic response in lung adenocarcinoma
by: Hui Jia, et al.
Published: (2023-01-01) -
Proteasome subunit PSMC3 variants cause neurosensory syndrome combining deafness and cataract due to proteotoxic stress
by: Ariane Kröll‐Hermi, et al.
Published: (2020-07-01)